VIROLOGIK GMBH has a total of 33 patent applications. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals and environmental technology are KIM SANG GEON, DE BAEREMAECKER BARROS CARLOS and FAULK PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | United States | 3 | |
#4 | Australia | 2 | |
#5 | Brazil | 2 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Germany | 2 | |
#9 | Israel | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | Norway | 2 | |
#13 | South Africa | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Schubert Ulrich | 27 |
#2 | Ludwig Stephan | 8 |
#3 | Planz Oliver | 8 |
#4 | Will Hans | 3 |
#5 | Sirma Hueseyin | 3 |
#6 | Ulrich Schubert | 3 |
#7 | Prassalow Alexij | 2 |
#8 | Schubert Evelyn | 2 |
#9 | Hohenberg Heinz | 2 |
#10 | Tessmer Uwe | 2 |
Publication | Filing date | Title |
---|---|---|
WO2011089167A1 | Kombination of proteasome inhibitors and anti -hepatitis medication for treating retroviral diseases | |
WO2011009961A1 | Combination of proteasome inhibitors and anti-hepatitis medication for treating hepatitis | |
DE102009028015A1 | Use of composition comprising proteasome inhibitor, nucleoside analog and interferon for producing an agent for treating hepatitis-C infection, and for treating against interferon and nucleoside analog resistant hepatitis-C virus infection | |
WO2008020085A2 | Use of chloro- and fluoromethyl ketone derivatives in anti-viral therapy | |
AU2007267082A1 | Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown | |
DE102006008321A1 | Agent for the treatment of infections with influenza viruses | |
EP2305291A1 | Use of proteasome inhibitors for the treatment of HIV infections |